Permanent Medicare Drug Price Negotiations
A new Centers for Medicare and Medicaid Services’ (CMS) regulation will set a permanent process and framework for Medicare drug price negotiations under the Inflation Reduction Act (IRA). This will ensure the program continues beyond 2029. The rule codifies and expands policies previously established through guidance for the initial 2026-28 period.
For the 2029 round, by Feb. 1 CMS will select up to 20 drugs covered under Medicare Part B or Part D for price negotiations, with the potential to also select medicines included in previous rounds for renegotiation.
I have championed the Trump administration’s efforts on drug prices across the board. This is yet another signal that Trump is serious. You would not have guessed that a Biden-era reform would have been so thoroughly endorsed.
#drugpricing #trump #medicare
Humana Q3 Financials
Humana beat The Street for both earnings and revenue in Q3 2026. The company reported $162 million in profit and $41.2 billion in revenue for Q3. Humana posted $195 million in profit and $32.6 billion in revenue for Q3 2025. Year to date, Humana earned $2 billion in profit and brought in $121.7 billion in revenue.
CEO Jim Rechtin told investors that the insurer expects its membership to grow again in 2027 despite plans to shed up to 600,000 in unprofitable areas. Humana saw a significant enrollment increase for 2026, which impacted financial performance. The CEO said it was too early to project the size of MA membership growth, but previous guidance said the company would have flat or decreased enrollment.
Humana has been buoyed by a huge win in terms of star ratings for Star Year 2027, payment year 2028.
The company said it is on track to achieve its pretax margin of 3% in 2028. The company’s medical loss ratio (MLR) grew to 93.9%, up 2.8 percentage points from the previous year.
Additional articles: https://www.fiercehealthcare.com/payers/humana-boosts-guidance-it-beats-street-both-profit-revenue-q3 and https://www.modernhealthcare.com/insurance/mh-humana-medicare-advantage-enrollment-2027
#medicareadvantage #healthplans #margins #humana
Cigna Report Q3 Financials
Cigna beat The Street in Q3 and boosted its 2026 financial outlook again. Better than expected financials were driven by both its health insurance and services entities.
Cigna reported income of $1.4 billion and $73.7 billion in revenue in Q3. Income was actually down from $1.9 billion in the same time last year.
Its services business Evernorth reported $1.8 billion in adjusted operating income, which was down 4% year over year.
#cigna #healthplans #margins
Two NSA Arbitrators Out
The Trump administration has ousted two arbitrators from the federal process used to resolve disputes between doctors and insurers over out-of-network bills under the No Surprises Act (NSA). Health plans and other critics applauded the move as a long-needed crackdown on alleged bias in favor of providers.
The Centers for Medicare and Medicaid Services (CMS) says it denied applications from Island Peer Review Organization and Network Medical Review Company to be recertified.
The NSA brought important reforms on surprise bills, but is terribly slanted to providers, driving up costs throughout the system. It is a wise move by the Trump administration and one concrete step toward reform.
#nsa #nosurprisesact #healthplans #providers #employercoverage
Hospital Sales Picking Up
Hospital sales are picking up steam as health systems under financial pressure look to right the ship and sell off underperforming assets. Large non-profit giants with heavy losses lead the pack in divesting.
#hospitals #margins #manda
— Marc S. Ryan
